靶向突变型雌激素受体。
Targeting mutant estrogen receptors.
机构信息
Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, United States.
出版信息
Elife. 2019 Jan 16;8:e44181. doi: 10.7554/eLife.44181.
Abstract
A drug used in hormone replacement therapy can target estrogen receptors that have become resistant to breast cancer treatments.
摘要
一种用于激素替代疗法的药物可以针对已经对乳腺癌治疗产生抗药性的雌激素受体。
Zotero 插件